TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 43 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $2,000 | – | 587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,255,691 | $7,173,000 | 5.84% |
| NEA Management Company, LLC | 2,086,755 | $6,636,000 | 0.26% |
| TOURADJI CAPITAL MANAGEMENT, LP | 10,000 | $32,000 | 0.10% |
| Loeb Offshore Management LP | 101,000 | $321,000 | 0.10% |
| BVF INC/IL | 150,000 | $477,000 | 0.08% |
| ABNER HERRMAN & BROCK LLC | 20,000 | $64,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 173,500 | $552,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 67,000 | $213,000 | 0.01% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 52,000 | $165,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 96,858 | $307,000 | 0.00% |